Literature DB >> 25875753

Prognostic Factors and Postoperative Recurrence of Calculus Following Small-Incision Sphincterotomy with Papillary Balloon Dilation for the Treatment of Intractable Choledocholithiasis: A 72-Month Follow-Up Study.

Hailian Mu1, Jianfei Gao, Qingyin Kong, Kaitong Jiang, Cuiyue Wang, Aihua Wang, Xianzhong Zeng, Yanqing Li.   

Abstract

OBJECTIVE: To evaluate the recurrence of common bile duct stones and risk factors for recurrence following routine endoscopic sphincterotomy (EST) versus small-incision endoscopic sphincterotomy plus endoscopic papillary balloon dilation (EST-EPBD).
METHODS: Three hundred patients who were hospitalized between June 2007 and June 2008 with common bile duct stones >10 mm in diameter were randomly assigned to the EST or EST-EPBD group. We compared the short-term (≤3 years) and long-term (>3 years) recurrence of ductal stones in the two groups over a 72-month follow-up period. Potential risk factors were evaluated using a logistic regression analysis.
RESULTS: A total of 291 patients completed the study. The short-term recurrence rate in the EST group was not significantly higher than that in the EST-EPBD group (P > 0.05). The long-term recurrence rate for the EST group was significantly higher than that for the EST-EPBD group (P < 0.05). The serum level of cholesterol, body mass index, gallstones, maximum stone diameter, number of stones, and mechanical lithotripsy were risk factors for the recurrence of ductal stones. Minimal size of the duodenal papilla incision was a protective factor with regard to the recurrence of ductal stones. Cholecystectomy, sex, and age were not associated with the recurrence of ductal stones.
CONCLUSIONS: Small-incision EST-EPBD has a similar overall success rate and a significantly lower rate of the recurrence of ductal stones, compared with those of EST alone. Thus, the curative effect of EST-EPBD is better than that of EST alone. Minimal size of the duodenal papilla incision protects against the recurrence of ductal stones.

Entities:  

Mesh:

Year:  2015        PMID: 25875753     DOI: 10.1007/s10620-015-3559-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

Review 1.  Endoscopic management of bile duct stones.

Authors:  Takao Itoi; Hsiu-Po Wang
Journal:  Dig Endosc       Date:  2010-07       Impact factor: 7.559

2.  Clinical utility of intraductal US to decrease early recurrence rate of common bile duct stones after endoscopic papillotomy.

Authors:  Shin Tsuchiya; Toshio Tsuyuguchi; Yuji Sakai; Harutoshi Sugiyama; Kaoru Miyagawa; Yoshihiro Fukuda; Takeshi Ando; Hiromitsu Saisho; Osamu Yokosuka
Journal:  J Gastroenterol Hepatol       Date:  2008-06-12       Impact factor: 4.029

Review 3.  Endoscopic management of bile duct stones.

Authors:  K F Binmoeller; T W Schafer
Journal:  J Clin Gastroenterol       Date:  2001-02       Impact factor: 3.062

4.  Endoscopic papillary large balloon dilation for the treatment of recurrent bile duct stones in patients with prior sphincterotomy.

Authors:  Kyeong Ok Kim; Tae Nyeun Kim; Si Hyung Lee
Journal:  J Gastroenterol       Date:  2010-07-16       Impact factor: 7.527

5.  Difficult bile duct stones.

Authors:  Lee McHenry; Glen Lehman
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

6.  Balloon sphincteroplasty for removing difficult bile duct stones.

Authors:  A Maydeo; S Bhandari
Journal:  Endoscopy       Date:  2007-08-15       Impact factor: 10.093

7.  Time-limited fluoroscopy to reduce radiation exposure during ERCP: a prospective randomized trial.

Authors:  Lance T Uradomo; Eric M Goldberg; Peter E Darwin
Journal:  Gastrointest Endosc       Date:  2007-07       Impact factor: 9.427

8.  Small sphincterotomy combined with papillary dilation with large balloon permits retrieval of large stones without mechanical lithotripsy.

Authors:  Atsushi Minami; Shinji Hirose; Tomohiro Nomoto; Shoichiro Hayakawa
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

9.  Choledocholithiasis: endoscopic versus laparoscopic management.

Authors:  M J Heili; N K Wintz; D L Fowler
Journal:  Am Surg       Date:  1999-02       Impact factor: 0.688

10.  Treatment of difficult bile duct stones using mechanical, electrohydraulic and extracorporeal shock wave lithotripsy.

Authors:  K F Binmoeller; M Brückner; F Thonke; N Soehendra
Journal:  Endoscopy       Date:  1993-03       Impact factor: 10.093

View more
  6 in total

1.  Sphincterotomy with Large Balloon to Extract Common Bile Duct Stones: Sometimes It Is Better to Get an "Incomplete".

Authors:  Fabrice Caillol
Journal:  Dig Dis Sci       Date:  2015-05-12       Impact factor: 3.199

2.  Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones.

Authors:  Christos Konstantakis; Christos Triantos; Vasileios Theopistos; Georgios Theocharis; Ioannis Maroulis; Georgia Diamantopoulou; Konstantinos Thomopoulos
Journal:  World J Gastrointest Endosc       Date:  2017-01-16

Review 3.  Advances in Risk Factors for Recurrence of Common Bile Duct Stones.

Authors:  Yao Wu; Chen Jing Xu; Shun Fu Xu
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

4.  Biliary Microbial Structure of Gallstone Patients With a History of Endoscopic Sphincterotomy Surgery.

Authors:  Hongzhang Shen; Juanjuan Zhu; Fuqiang Ye; Dongchao Xu; Liangliang Fang; Jianfeng Yang; Huijie Lv; Qifeng Lou; Hangbin Jin; Ming Ni; Xiaofeng Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-01-27       Impact factor: 5.293

5.  New common bile duct morphological subtypes: Risk predictors of common bile duct stone recurrence.

Authors:  Xu Ji; Zhuo Yang; Shu-Ren Ma; Wen Jia; Qian Zhao; Lu Xu; Ying Kan; Yang Cao; Yao Wang; Bao-Jun Fan
Journal:  World J Gastrointest Surg       Date:  2022-03-27

6.  Risk factors for recurrence of common bile duct stones after endoscopic biliary sphincterotomy.

Authors:  Sujuan Li; Bingzhong Su; Ping Chen; Jianyu Hao
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.